Functional analysis of lung tumor suppressor activity at 3p21.3

Genes Chromosomes and Cancer

Volumn 45, Issue 12, 2006, Pages 1077-1093

  Ter Elst, Arja ^a   Hiemstra, Bea E ^a   Van Der Vlies, Pieter ^a   Kamminga, Wytske ^a   Van Der Veen, Anneke Y ^a   Davelaar, Inge ^a   Terpstra, Peter ^a   Te Meerman, Gerard J ^a   Gerbens, Frans ^a   Kok, Klaas ^a   Buys, Charles H C M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL CHROMOSOME; CELL CLONE; CELL GROWTH; CENTROMERE; CHROMOSOMAL INSTABILITY; CHROMOSOME 3P; CHROMOSOME DELETION; CLONING VECTOR; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; GROWTH INHIBITION; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOMES, ARTIFICIAL, P1 BACTERIOPHAGE; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 33751100403     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20367     Document Type: Article

References (36)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F. 2001. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20:1509-1518.
2. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K. 2004. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 64:3198-3208.
3. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. 2005. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21-24.
4. Breedveld GJ, van Dongen JW, Danesino C, Guala A, Percy AK, Dure LS, Harper P, Lazarou LP, van der Linde H, Joosse M, Gruters A, MacDonald ME, de Vries BB, Arts WF, Oostra BA, Krude H, Heutink P. 2002. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 11:971-979.
5. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Toyooka S, Gazdar AF, Lerman MI, Zabarovsky E, White M, Minna JD. 2001. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93:691-699.
6. Chen W, Erdogan F, Ropers HH, Lenzner S, Ullmann R. 2005. CGHPRO-A comprehensive data analysis tool for array CGH. BMC Bioinformatics 6:85-91.
7. Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. 2004. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109:839-847.
8. Daly MC, Xiang RH, Buchhagen D, Hensel CH, Garcia DK, Killary AM, Minna JD, Naylor SL. 1993. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene 8:1721-1729.
9. Dammann R, Takahashi T, Pfeifer GP. 2001. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 20:3563-3567.
10. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER. 2001. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98:7504-7509.
11. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE, Smith J, Vetrie D, Gorman P, Tomlinson IP, Carter NP. 2003. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAG and PAC clones. Genes Chromosomes Cancer 36:361-374.
12. Fraizer GC, Diaz MF, Lee IL, Grossman HB, Sen S. 2004. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int J Oncol 25:1631-1639.
13. Frengen E, Zhao B, Howe S, Weichenhan D, Osoegawa K, Gjernes E, Jessee J, Prydz H, Huxley C, de Jong PJ. 2000. Modular bacterial artificial chromosome vectors for transfer of large inserts into mammalian cells. Genomics 68:118-126.
14. Hermouet S, Aznavoorian S, Spiegel AM. 1996. In vitro and in vivo growth inhibition of murine melanoma K-1735 cell by a dominant negative mutant α subunit of the Gi2 protein. Cell Signal 8:159-166.
15. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamihayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, Minna JD. 2002. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 62:2715-2720.
16. Kim D, Pemberton H, Stratford AL, Buelaert K, Watkinson JC, Lopes V, Kranklyn JA, McCabe CJ. 2005. Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene 24:4861-4866.
17. Kok K, Naylor SL, Buys CHCM. 1997. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71:27-92.
18. Kok K, van den Berg A, Veldhuis PMJF, van der Veen AY, Kranke M, Schoenmakers EFPM, Hulsbeek MMF, van der Hout AH, de Leij LFMH, van de Ven W, Buys CHCM. 1994. A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res 54:4183-4187.
19. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. 2003. New microRNAs from mouse and human. RNA 9:175-183.
20. Lerman MI, Minna JD. 2000. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium [In Process Citation]. Cancer Res 60:6116-6133.
21. Li J, Wang K, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E. 2004. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogenc 23:5941-5949.
22. Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX. 2003. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 106:60-64.
23. Oh JJ, West AR, Fishbein MC, Slamon DJ. 2002. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res 62:3207-3213.
24. Riley J, Butler R, Ogilvie D, Finniear R, Jenner D, Powell S, Anand R, Smith JC, Markham AF. 1990. A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res 18:2887-2890.
25. Roche J, Boldog K, Robinson M, Robinson L, VarellaGarcia M, Swanton M, Waggoner B, Fishel R, Franklin W, Gemmill R, Drabkin H. 1996. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12:1289-1297.
26. Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG. 2005. Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. Cancer Res 65:1361-1368.
27. Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai T, Yoda K, Nomura F. 2005. Centromere protein H is upregulated in primary human colorecral cancer and its overexpression induces aneuploidy. Cancer Res 265:4683-4691.
28. Toyooka S, Toyooka KO, Maruyama R, Virmani Ak, Girard L, Miyajima K, Harada K, Ariyoshi Y, Takahashi T, Sugio K, Brambilla E, Gilcrease M, Minna JD, Gazdar AF. 2001. DNA methylation profiles of lung tumors. Mol Cancer Ther 1:61-67.
29. Tse C, Xiang RH, Bracht T, Naylor SL. 2002. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor-formation in an adenocarcinoma cell line. Cancer Res 62:542-547.
30. van der Hout AH, Kok K, van der Veen AY, Osinga J, de Leij LFMH, Buys CHCM. 1989. Localisation of amplified c-myc and n-myc in small cell lung cancer cell lines. Cancer Genet Cytogenet 38:1-8.
31. Wei MH, Latif F, Bader S, Kashuba V, Chen JY, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD, Lerman MI. 1996. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: Progress toward the isolation of a lung cancer TSG. Cancer Res 56:1487-1492.
32. Wistuba H, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF. 1997. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366-1373.
33. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL. 2002. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res 62:2637-2643.
34. Zabarovsky ER, Lerman MI, Minna JD. 2002. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21:6915-6935.
35. Whang-Peng J, Bunn Pa, Kao-Shan CS, Lee EC, Carney DN, Gazdar AF, Minna JD. 1982a. A non-random chromosome abnormality, dcl3p(14-23) in human small cell lung cancer. Cancer Genet Cytogenet 6:119-134.
36. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Minna JD. 1982b. Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23). Science 251:181-182.